Stockreport

Calluna Pharma appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board [Yahoo! Finance]

Cyclerion Therapeutics, Inc.  (CYCN) 
PDF Gaffney brings over 20 years of experience in corporate strategy, business development, and operations in both private and public biotechnology companies, and will lead [Read more]